Cancer clinical trials in the region Auvergne-Rhône-Alpes
328 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Anal cancer
#NCT06207981
#2023-505972-32-00
Locally Advanced
Radiotherapy
Radiotherapy
Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Hospitalier Métropole Savoie (Chambéry)
Fédération Francophone de Cancérologie Digestive
Phase 3
Breast cancer
#NCT05952557
#2023-504031-41-00
HER2 Negative
HR Positive
Localized
None
Surgery
Chemotherapy
Radiotherapy
Hormone therapy
Systemic Treatment-Naive
CHU Saint-Étienne (Saint-Priest-en-Jarez), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy)
AstraZeneca
Phase 3
Stomach and esophageal cancer
#NCT06346197
#2023-506291-28-00
Stomach
Oesogastric junction
Esophagus
Adenocarcinoma
Locally Advanced
Metastatic
MSI/dMMR
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
HER2
Immunotherapy
Immunotherapy
Centre Léon Bérard (Lyon)
Centre Léon Bérard
Phase 3
Lymphoma
CLL & Richter's syndrome
#NCT06973187
#2025-522860-34-00
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Lymphocytic lymphoma
1
2
3 or more
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
BeiGene
Phase 3
Bladder / Urinary Tract / Urethral cancer
#NCT06510374
Non-invasive bladder cancer
Urothelial carcinoma
Localized
None
Surgery
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
Ferring Pharmaceuticals